The first stop for professional medicines advice

Patient Group Directions

139 results

Applied filters

Patient Group Direction use in End of Life Care

10 August 2020Considerations required before implementing Patient Group Directions (PGDs) in End of Life Care.

PGD use in services provided by multiple organisations

14 July 2020Principles to be considered are outlined for Patient Group Directions used in the provision of medicines/vaccines in services provided by multiple organisations

Patient Specific Directions (PSD)

10 June 2020This article describes Patient Specific Directions and the requirements for their writing and use

Bank and agency staff and Patient Group Directions

25 February 2020The below summarises the advice on the use of PGDs by bank and agency staff working within organisations.

Off-label or unlicensed product use under HMR 2012 exemptions

8 January 2020A legal position summary regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the Human Medicines Regulations 2012

Patient Group Direction use in Primary Care Networks

8 January 2020Guidance on the legislation and governance required when considering the use of PGDs across a PCN

Medicines Shortages and Patient Group Directions

16 December 2019This article outlines how PGDs can be managed to allow for their continued use in cases of medicines shortages.

Using medicines under PGD as part of a clinical trial or study

26 June 2019Advice on the use of Patient Group Directions (PGDs) to supply or administer a medication which is part of a clinical trial, study or pilot

SPS National Patient Group Direction (PGD) exemplar templates

20 June 2019The SPS National Medicines Governance Do Once programme produce national Patient Group Direction (PGD) exemplar templates for local adaptation